RE:RE:RE:RE:RE:Pretty impressiveIts normal that there a drop after a run up. From $1.39 to $1.88. Its always good to take a profit. Need to keep the focus on the long run.... Insider are buying at these levels and that's always a good indications. Lets not forget why we are here. Paradigm Capital reaffirmed a buy rating and issued a C$3.75 price target on shares of ProMetic Life Sciences in a research report on Monday, September 28th. Canaccord Genuity lowered their price objective on ProMetic Life Sciences to C$3.50 and set a buy rating on the stock in a research report on Monday, August 17th. Finally, Scotiabank set a C$3.00 price target on ProMetic Life Sciences and gave the company an outperform rating in a research report on Thursday, July 9th. Five equities research analysts have rated the stock with a buy rating, The company has an average rating of Buy and a consensus target price of C$3.33.